chr6-64886797-T-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. PP5BP4

The NM_001142800.2(EYS):​c.2892A>C​(p.Glu964Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,546,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E964K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

EYS
NM_001142800.2 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3

Conservation

PhyloP100: 0.314

Publications

0 publications found
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
EYS Gene-Disease associations (from GenCC):
  • EYS-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • retinitis pigmentosa 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PP5
Variant 6-64886797-T-G is Pathogenic according to our data. Variant chr6-64886797-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 554346.
BP4
Computational evidence support a benign effect (MetaRNN=0.057252854). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001142800.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYS
NM_001142800.2
MANE Select
c.2892A>Cp.Glu964Asp
missense
Exon 19 of 43NP_001136272.1
EYS
NM_001292009.2
c.2892A>Cp.Glu964Asp
missense
Exon 19 of 44NP_001278938.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYS
ENST00000503581.6
TSL:5 MANE Select
c.2892A>Cp.Glu964Asp
missense
Exon 19 of 43ENSP00000424243.1
EYS
ENST00000370621.7
TSL:1
c.2892A>Cp.Glu964Asp
missense
Exon 19 of 44ENSP00000359655.3

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151850
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000581
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000519
AC:
8
AN:
154094
AF XY:
0.0000735
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000657
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000151
AC:
21
AN:
1394772
Hom.:
0
Cov.:
29
AF XY:
0.0000160
AC XY:
11
AN XY:
687910
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31310
American (AMR)
AF:
0.00
AC:
0
AN:
35320
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25082
East Asian (EAS)
AF:
0.000451
AC:
16
AN:
35468
South Asian (SAS)
AF:
0.0000381
AC:
3
AN:
78652
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49256
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5670
European-Non Finnish (NFE)
AF:
9.29e-7
AC:
1
AN:
1076204
Other (OTH)
AF:
0.0000173
AC:
1
AN:
57810
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.439
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
151968
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41488
American (AMR)
AF:
0.00
AC:
0
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.000583
AC:
3
AN:
5148
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67956
Other (OTH)
AF:
0.00
AC:
0
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000388
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000814
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Retinal dystrophy Pathogenic:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

not specified Uncertain:1
Dec 15, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: EYS c.2892A>C (p.Glu964Asp) results in a conservative amino acid change in the encoded protein sequence. Four of four in-silico tools predict a benign effect of the variant on protein function. c.2892A>C has been reported in the literature as co-occurring with EYS c.2886C>G (p.Phe962Leu) in all instances ascertained among individuals affected with features of Leber congenital amaurosis (LCA) (example, Eisenberger_2013) or Retinitis Pigmentosa (example, Koyanagi_2019, Numa_2020, Gao_2022). In at-least two of these ascertainments, this variant combination also occurred along with a third EYS allele, again without phase specifications, among individuals affected with Retinitis Pigmentosa (n=2, c.8868delT (p.Ala2957fs), Koyanagi_2019 and n=1, c.2582G>A (p.Gly843Asp), Numa_2020). Furthermore, this variant combination also occurred without phase specifications, and therefore as a non-informative genotype alongside a majority concordant benign/likely benign EYS variant c.5510G>C (p.Trp1837Ser) in an individual with LCA (Eisenberger_2013). These report(s) do not provide unequivocal conclusions about association of the variant with Retinitis Pigmentosa or Leber congenital amaurosis. Both these variant alleles are found at a frequency of 5.2e-05 in 154094 and 153916 control chromosomes respectively in the gnomAD (v2) database, further supporting a co-occuring haplotype. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24265693, 34689181, 31213501, 33247286). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant in isolation was classified as uncertain significance.

not provided Uncertain:1
Oct 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 964 of the EYS protein (p.Glu964Asp). This variant is present in population databases (rs762212630, gnomAD 0.06%). This missense change has been observed in individual(s) with EYS-related conditions (PMID: 24265693, 33247286). ClinVar contains an entry for this variant (Variation ID: 554346). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on EYS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Retinitis pigmentosa 25 Uncertain:1
Oct 16, 2017
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
4.4
DANN
Uncertain
0.99
DEOGEN2
Benign
0.025
T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.45
T
M_CAP
Uncertain
0.099
D
MetaRNN
Benign
0.057
T
MetaSVM
Benign
-0.50
T
MutationAssessor
Benign
1.4
L
PhyloP100
0.31
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.26
Sift
Benign
0.063
T
Sift4G
Uncertain
0.038
D
Polyphen
0.58
P
Vest4
0.23
MutPred
0.47
Loss of ubiquitination at K969 (P = 0.0768)
MVP
0.37
MPC
0.060
ClinPred
0.059
T
GERP RS
2.7
Varity_R
0.10
gMVP
0.74
Mutation Taster
=50/50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs762212630; hg19: chr6-65596690; API